IE Pharmaceuticals

Keenova Therapeutics PLC (MCKPF)

Track

Over the past 90 days, Keenova Therapeutics PLC has seen two insider trading transactions, both involving buy orders from Silver Point Capital L.P. These transactions totaled approximately $35.97 million in value. There have been no reported insider sales during this period, reflecting a consistent pattern of accumulation by this institutional investor.
Ticker: MCKPF Exchange: PNK
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Silver Point Capital L.P.
1 purchase — total 19,005,000 USD
Buy 20 May 2026
Value US$4,084,738.60 | Price 448.92 | Shares 83,258
Buy 19 May 2026
Value US$2,210,849.49 | Price 481.67 | Shares 3,356
Buy 17 Apr 2026
Value US$37,105,000.00 | Price 90.50 | Shares 410,000
Buy 15 Apr 2026
Value US$24,337,500.00 | Price 88.50 | Shares 275,000
Buy 7 Jan 2026
Value US$23,062,500.00 | Price 92.25 | Shares 250,000
Buy 8 Dec 2025
Value US$11,623,942.50 | Price 88.75 | Shares 130,974
Buy 19 Nov 2025
Value US$3,732,750.00 | Price 88.88 | Shares 42,000
Buy 17 Nov 2025
Value US$2,310,750.00 | Price 88.88 | Shares 26,000
Buy 10 Nov 2025
Value US$27,187,500.00 | Price 93.75 | Shares 290,000
Buy 6 Aug 2025
Value US$619,750.00 | Price 92.50 | Shares 6,700
Buy 4 Aug 2025
Value US$2,617,500.00 | Price 87.25 | Shares 30,000
Buy 1 Aug 2025
Value US$4,325,000.00 | Price 86.50 | Shares 50,000
Buy 8 Jul 2024
Value US$724,850.00 | Price 54.50 | Shares 13,300
Buy 14 Jun 2024
Value US$14,506,250.00 | Price 52.75 | Shares 275,000
Buy 24 May 2024
Value US$8,250,000.00 | Price 50.00 | Shares 165,000
Buy 9 May 2024
Value US$19,425,000.00 | Price 55.50 | Shares 350,000
Buy 9 May 2024
Value US$6,875,000.00 | Price 55.00 | Shares 125,000
Buy 8 Mar 2024
Value US$3,620,875.00 | Price 43.63 | Shares 83,000
Buy 15 Feb 2024
Value US$8,606,250.00 | Price 38.25 | Shares 225,000
Buy 2 Feb 2024
Value US$751,000.00 | Price 37.55 | Shares 20,000
Buy 5 Dec 2023
Value US$2,812,500.00 | Price 37.50 | Shares 75,000
Proposed sale 15 Nov 2023
Value US$5,005,000.00 | Price 38.50 | Shares 130,000
Buy 16 Mar 2023
Value US$7,823.39 | Price 8.39 | Shares 933
Buy 16 Mar 2023
Value US$1,670.00 | Price 8.35 | Shares 200
Buy 15 Mar 2023
Value US$128,155.50 | Price 8.54 | Shares 15,000
Buy 14 Mar 2023
Value US$42,329.50 | Price 8.47 | Shares 5,000
Buy 14 Mar 2023
Value US$126,319.50 | Price 8.42 | Shares 15,000
Buy 13 Mar 2023
Value US$8,479.90 | Price 8.48 | Shares 1,000
Buy 13 Mar 2023
Value US$25,121.40 | Price 8.37 | Shares 3,000
Sale 17 Mar 2022
Value US$2,575.34 | Price 0.12 | Shares 22,087
Sale 17 Mar 2022
Value US$1,401.43 | Price 0.12 | Shares 11,978
Sale 12 Mar 2021
Value US$12,581.18 | Price 0.40 | Shares 31,398
Sale 12 Mar 2021
Value US$4,274.27 | Price 0.40 | Shares 10,667
Sale 12 Mar 2021
Value US$6,715.38 | Price 0.40 | Shares 16,614
Sale 17 Dec 2020
Value US$6,880.95 | Price 0.45 | Shares 15,291
Sale 17 Dec 2020
Value US$2,054.35 | Price 0.40 | Shares 5,080
Sale 16 Dec 2020
Value US$9,462.06 | Price 0.43 | Shares 21,807
Sale 7 Dec 2020
Value US$2,197.94 | Price 0.14 | Shares 16,020
Sale 4 Dec 2020
Value US$4,482.75 | Price 0.14 | Shares 31,087
Sale 3 Dec 2020
Value US$891.00 | Price 0.17 | Shares 5,400
Sale 16 Nov 2020
Value US$94.28 | Price 0.13 | Shares 750
Sale 12 Nov 2020
Value US$6,665.24 | Price 0.13 | Shares 51,789
Sale 12 Nov 2020
Value US$27,394.49 | Price 0.13 | Shares 217,072
Sale 11 Nov 2020
Value US$4,495.53 | Price 0.13 | Shares 34,581
Sale 6 Nov 2020
Value US$2,741.31 | Price 0.13 | Shares 21,087
Sale 6 Nov 2020
Value US$5,040.28 | Price 0.13 | Shares 38,300
Buy 7 Jun 2019
Value US$48,383.46 | Price 8.96 | Shares 5,400
Buy 30 May 2019
Value US$18,528.00 | Price 9.26 | Shares 2,000
Planned buy 9 May 2019
Value US$16,325.00 | Price 16.33 | Shares 1,000
Buy 5 Mar 2019
Value US$22,650.00 | Price 22.65 | Shares 1,000
Planned buy 10 Dec 2018
Value US$20,180.10 | Price 20.18 | Shares 1,000
Planned buy 16 May 2018
Value US$46,614.60 | Price 15.54 | Shares 3,000
Sale 9 May 2018
Value US$2,775,562.44 | Price 13.74 | Shares 202,006
Sale 9 May 2018
Value US$1,414,255.50 | Price 12.75 | Shares 110,922
Buy 28 Nov 2017
Value US$100,046.40 | Price 21.94 | Shares 4,560
Planned buy 14 Nov 2017
Value US$42,156.00 | Price 21.08 | Shares 2,000
Planned buy 14 Nov 2017
Value US$196,200.00 | Price 21.80 | Shares 9,000
Buy 13 Nov 2017
Value US$21,500.00 | Price 21.50 | Shares 1,000
Buy 13 Nov 2017
Value US$106,500.00 | Price 21.30 | Shares 5,000
Buy 13 Nov 2017
Value US$218,236.00 | Price 21.82 | Shares 10,000
Buy 13 Nov 2017
Value US$31,950.00 | Price 21.30 | Shares 1,500
Planned buy 13 Nov 2017
Value US$43,920.00 | Price 21.96 | Shares 2,000
Planned buy 10 Nov 2017
Value US$111,401.50 | Price 22.28 | Shares 5,000
Buy 10 Nov 2017
Value US$44,030.00 | Price 22.02 | Shares 2,000
Planned buy 9 Nov 2017
Value US$164,308.94 | Price 20.80 | Shares 7,900
Buy 9 Nov 2017
Value US$102,093.50 | Price 20.42 | Shares 5,000
Buy 9 Nov 2017
Value US$218,349.00 | Price 21.83 | Shares 10,000
Planned buy 30 Aug 2017
Value US$50,725.25 | Price 39.63 | Shares 1,280
Planned buy 9 Jun 2017
Value US$39,881.00 | Price 39.88 | Shares 1,000
Buy 9 Jun 2017
Value US$55,678.00 | Price 39.77 | Shares 1,400
Buy 9 Jun 2017
Value US$61,825.00 | Price 39.89 | Shares 1,550
Planned buy 9 Jun 2017
Value US$206,320.00 | Price 41.26 | Shares 5,000
Planned buy 9 Jun 2017
Value US$40,173.50 | Price 40.17 | Shares 1,000
Planned buy 8 Jun 2017
Value US$40,236.80 | Price 40.24 | Shares 1,000
Buy 5 Jun 2017
Value US$19,665.00 | Price 39.33 | Shares 500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-21 2026-05-20 B Purchase
2.9
Silver Point Capital L.P.
Large shareholder
83,258 +26.3%
448.92
US$4,084,739 		83,258 +26.3% 448.92 US$4,084,739
2026-05-21 2026-05-19 B Purchase
2.9
Silver Point Capital L.P.
Large shareholder
3,356 +14.1%
481.67
US$2,210,849 		3,356 +14.1% 481.67 US$2,210,849
2026-04-17 2026-04-17 B Purchase
2.9
Silver Point Capital L.P.
Large shareholder
59,032 -41.0%
400.60
US$1,948,595 		59,032 -41.0% 400.60 US$1,948,595
2026-04-17 2026-04-15 B Purchase
2.9
Silver Point Capital L.P.
Large shareholder
275,000 +5.6%
88.50
US$24,337,500 		275,000 +5.6% 88.50 US$24,337,500
2026-01-09 2026-01-07 B Purchase
2.9
Silver Point Capital L.P.
Large shareholder
250,000 +5.3%
92.25
US$23,062,500 		250,000 +5.3% 92.25 US$23,062,500
2025-12-10 2025-12-08 B Purchase
2.9
Silver Point Capital L.P.
Large shareholder
130,974 +2.9%
88.75
US$11,623,942 		130,974 +2.9% 88.75 US$11,623,942
2025-11-19 2025-11-19 B Purchase
2.9
Silver Point Capital L.P.
Large shareholder
42,000 +0.9%
88.88
US$3,732,750 		42,000 +0.9% 88.88 US$3,732,750
2025-11-19 2025-11-17 B Purchase
2.9
Silver Point Capital L.P.
Large shareholder
26,000 +0.6%
88.88
US$2,310,750 		26,000 +0.6% 88.88 US$2,310,750
2025-11-12 2025-11-10 B Purchase
2.9
Silver Point Capital L.P.
Large shareholder
290,000 +6.9%
93.75
US$27,187,500 		290,000 +6.9% 93.75 US$27,187,500
2025-08-06 2025-08-06 B Purchase
2.7
GOLDENTREE ASSET MANAGEMENT LP
Large shareholder
6,700 +0.1%
92.50
US$619,750 		6,700 +0.1% 92.50 US$619,750
2025-08-06 2025-08-04 B Purchase
2.7
GOLDENTREE ASSET MANAGEMENT LP
Large shareholder
30,000 +0.4%
87.25
US$2,617,500 		30,000 +0.4% 87.25 US$2,617,500
2025-08-04 2025-08-01 B Purchase
2.7
GOLDENTREE ASSET MANAGEMENT LP
Large shareholder
50,000 +0.6%
86.50
US$4,325,000 		50,000 +0.6% 86.50 US$4,325,000
2024-07-10 2024-07-08 B Purchase
2.7
GOLDENTREE ASSET MANAGEMENT LP
Large shareholder
13,300 +0.4%
54.50
US$724,850 		13,300 +0.4% 54.50 US$724,850
2024-06-18 2024-06-14 B Purchase
2.7
GOLDENTREE ASSET MANAGEMENT LP
Large shareholder
275,000 +9.0%
52.75
US$14,506,250 		275,000 +9.0% 52.75 US$14,506,250
2024-05-29 2024-05-24 B Purchase
2.7
GOLDENTREE ASSET MANAGEMENT LP
Large shareholder
165,000 +5.7%
50.00
US$8,250,000 		165,000 +5.7% 50.00 US$8,250,000
2024-05-13 2024-05-09 B Purchase
2.7
GOLDENTREE ASSET MANAGEMENT LP
Large shareholder
350,000 +13.9%
55.50
US$19,425,000 		350,000 +13.9% 55.50 US$19,425,000
2024-05-13 2024-05-09 B Purchase
2.7
GOLDENTREE ASSET MANAGEMENT LP
Large shareholder
125,000 +5.2%
55.00
US$6,875,000 		125,000 +5.2% 55.00 US$6,875,000
2024-03-12 2024-03-08 B Purchase
2.7
GOLDENTREE ASSET MANAGEMENT LP
Large shareholder
83,000 +3.6%
43.63
US$3,620,875 		83,000 +3.6% 43.63 US$3,620,875
2024-02-20 2024-02-15 B Purchase
2.7
GOLDENTREE ASSET MANAGEMENT LP
Large shareholder
225,000 +10.8%
38.25
US$8,606,250 		225,000 +10.8% 38.25 US$8,606,250
2024-02-06 2024-02-02 B Purchase
2.7
GOLDENTREE ASSET MANAGEMENT LP
Large shareholder
20,000 +1.0%
37.55
US$751,000 		20,000 +1.0% 37.55 US$751,000
2023-12-13 2023-12-05 B Purchase
2.7
GOLDENTREE ASSET MANAGEMENT LP
Large shareholder
75,000 +3.8%
37.50
US$2,812,500 		75,000 +3.8% 37.50 US$2,812,500
2023-11-28 2023-11-15 PrS Proposed sale
2.9
Silver Point Capital L.P.

Director

Non-Executive Director
130,000
38.50
US$5,005,000 		130,000 38.50 US$5,005,000
2023-03-17 2023-03-16 B Purchase
0.5
Goodson Jason Daniel

EVP & Head of Corp Development

Officer
933 +2.5%
8.39
US$7,823 		933 +2.5% 8.39 US$7,823
2023-03-17 2023-03-16 B Purchase
0.5
Goodson Jason Daniel

EVP & Head of Corp Development

Officer
200 +0.5%
8.35
US$1,670 		200 +0.5% 8.35 US$1,670
2023-03-16 2023-03-15 B Purchase
1.6
SULAT JAMES R
Non-Executive Director
15,000 +22.2%
8.54
US$128,156 		15,000 +22.2% 8.54 US$128,156
2023-03-16 2023-03-14 B Purchase
2.3
BISARO PAUL
Non-Executive Director
5,000 +7.2%
8.47
US$42,330 		5,000 +7.2% 8.47 US$42,330
2023-03-16 2023-03-14 B Purchase
1.6
SULAT JAMES R
Non-Executive Director
15,000 +28.5%
8.42
US$126,320 		15,000 +28.5% 8.42 US$126,320
2023-03-15 2023-03-13 B Purchase
0.5
Welch Stephen Andrew

EVP & Head of Spec Generics

Officer
1,000 +2.7%
8.48
US$8,480 		1,000 +2.7% 8.48 US$8,480
2023-03-15 2023-03-13 B Purchase
3.0
Olafsson Sigurdur O

President and CEO

Executive Director
3,000 +1.3%
8.37
US$25,121 		3,000 +1.3% 8.37 US$25,121
2022-03-21 2022-03-17 S Sale
2.5
REED JOANN A
Non-Executive Director
22,087 -100.0%
0.12
US$2,575 		22,087 -100.0% 0.12 US$2,575
2022-03-21 2022-03-17 S Sale
2.5
REED JOANN A
Non-Executive Director
11,978 -35.2%
0.12
US$1,401 		11,978 -35.2% 0.12 US$1,401
2021-03-16 2021-03-12 S Sale
2.7
CARROLL J MARTIN
Non-Executive Director
31,398 -100.0%
0.40
US$12,581 		31,398 -100.0% 0.40 US$12,581
2021-03-16 2021-03-12 S Sale
2.7
CARROLL J MARTIN
Non-Executive Director
10,667 -100.0%
0.40
US$4,274 		10,667 -100.0% 0.40 US$4,274
2021-03-16 2021-03-12 S Sale
0.5
Paya Carlos V
Non-Executive Director
16,614 -100.0%
0.40
US$6,715 		16,614 -100.0% 0.40 US$6,715
2020-12-18 2020-12-17 S Sale
0.5
Casey Mark J

EVP and Chief Legal Officer

Officer
15,291 -32.3%
0.45
US$6,881 		15,291 -32.3% 0.45 US$6,881
2020-12-18 2020-12-17 S Sale
1.0
Norton David Y
Non-Executive Director
5,080 -100.0%
0.40
US$2,054 		5,080 -100.0% 0.40 US$2,054
2020-12-18 2020-12-16 S Sale
1.0
Norton David Y
Non-Executive Director
21,807 -81.1%
0.43
US$9,462 		21,807 -81.1% 0.43 US$9,462
2020-12-07 2020-12-07 S Sale
0.9
CARLUCCI DAVID R
Non-Executive Director
16,020 -100.0%
0.14
US$2,198 		16,020 -100.0% 0.14 US$2,198
2020-12-07 2020-12-04 S Sale
0.9
CARLUCCI DAVID R
Non-Executive Director
31,087 -66.0%
0.14
US$4,483 		31,087 -66.0% 0.14 US$4,483
2020-12-07 2020-12-03 S Sale
1.0
Reasons Bryan M.

EVP & CFO

Officer
5,400 -31.8%
0.17
US$891 		5,400 -31.8% 0.17 US$891
2020-11-18 2020-11-16 S Sale
0.5
O'Neill Hugh M.

EVP & Chief Comm & Ops Ofcr

Officer
750 -0.9%
0.13
US$94 		750 -0.9% 0.13 US$94
2020-11-16 2020-11-12 S Sale
1.4
Russell Angus C.
Non-Executive Director
51,789 -100.0%
0.13
US$6,665 		51,789 -100.0% 0.13 US$6,665
2020-11-16 2020-11-12 S Sale
0.8
Trudeau Mark

President and CEO

Executive Director
217,072 -95.0%
0.13
US$27,394 		217,072 -95.0% 0.13 US$27,394
2020-11-13 2020-11-11 S Sale
0.5
WATKINS IAN J

EVP and Chief HR Officer

Officer
34,581 -65.4%
0.13
US$4,496 		34,581 -65.4% 0.13 US$4,496
2020-11-10 2020-11-06 S Sale
0.5
Whitaker Anne Clem
Non-Executive Director
21,087 -100.0%
0.13
US$2,741 		21,087 -100.0% 0.13 US$2,741
2020-11-10 2020-11-06 S Sale
0.5
YOUNGBLOOD DR KNEELAND
Non-Executive Director
38,300 -100.0%
0.13
US$5,040 		38,300 -100.0% 0.13 US$5,040
2019-06-07 2019-06-07 B Purchase
1.0
Reasons Bryan M.

EVP & CFO
5,400 +42.9%
8.96
US$48,383 		5,400 +42.9% 8.96 US$48,383
2019-05-31 2019-05-30 B Purchase
0.8
Trudeau Mark

President and CEO

Executive Director
2,000 +0.9%
9.26
US$18,528 		2,000 +0.9% 9.26 US$18,528
2019-05-10 2019-05-09 PP Planned purchase
0.8
Trudeau Mark

President and CEO

Executive Director
1,000 +0.4%
16.33
US$16,325 		1,000 +0.4% 16.33 US$16,325
2019-03-06 2019-03-05 B Purchase
0.8
Trudeau Mark

President and CEO

Executive Director
1,000 +0.4%
22.65
US$22,650 		1,000 +0.4% 22.65 US$22,650
2018-12-11 2018-12-10 PP Planned purchase Trudeau Mark

President and CEO

Executive Director
1,000 +0.4%
20.18
US$20,180 		1,000 +0.4% 20.18 US$20,180
2018-05-18 2018-05-16 PP Planned purchase Trudeau Mark

President and CEO

Executive Director
3,000 +1.1%
15.54
US$46,615 		3,000 +1.1% 15.54 US$46,615
2018-05-10 2018-05-09 S Sale Flynn James E Large shareholder
202,006 -2.4%
13.74
US$2,775,562 		202,006 -2.4% 13.74 US$2,775,562
2018-05-10 2018-05-09 S Sale Flynn James E Large shareholder
110,922 -1.3%
12.75
US$1,414,256 		110,922 -1.3% 12.75 US$1,414,256
2017-11-30 2017-11-28 B Purchase YOUNGBLOOD DR KNEELAND
4,560 +29.9%
21.94
US$100,046 		4,560 +29.9% 21.94 US$100,046
2017-11-15 2017-11-14 PP Planned purchase WATKINS IAN J

Chief HR Officer
2,000 +7.5%
21.08
US$42,156 		2,000 +7.5% 21.08 US$42,156
2017-11-15 2017-11-14 PP Planned purchase O'Neill Hugh M.

Exec. VP & Pres, ARD
9,000 +28.8%
21.80
US$196,200 		9,000 +28.8% 21.80 US$196,200
2017-11-13 2017-11-13 B Purchase REED JOANN A
1,000 +6.9%
21.50
US$21,500 		1,000 +6.9% 21.50 US$21,500
2017-11-13 2017-11-13 B Purchase ZACCAGNINO JOSEPH A
5,000 +23.7%
21.30
US$106,500 		5,000 +23.7% 21.30 US$106,500
2017-11-13 2017-11-13 B Purchase BOOTH MELVIN D
10,000 +126.6%
21.82
US$218,236 		10,000 +126.6% 21.82 US$218,236
2017-11-13 2017-11-13 B Purchase Gulyas Diane H.
1,500 +8.1%
21.30
US$31,950 		1,500 +8.1% 21.30 US$31,950
2017-11-13 2017-11-13 PP Planned purchase Romano Steven J.

Exec. VP & Chief Sci. Ofcr
2,000 +9.0%
21.96
US$43,920 		2,000 +9.0% 21.96 US$43,920
2017-11-13 2017-11-10 PP Planned purchase Trudeau Mark

President and CEO

Executive Director
5,000 +1.9%
22.28
US$111,402 		5,000 +1.9% 22.28 US$111,402
2017-11-13 2017-11-10 B Purchase Norton David Y
2,000 +35.7%
22.02
US$44,030 		2,000 +35.7% 22.02 US$44,030
2017-11-13 2017-11-09 PP Planned purchase Hicks Michael-Bryant

General Counsel
7,900 +88.7%
20.80
US$164,309 		7,900 +88.7% 20.80 US$164,309
2017-11-13 2017-11-09 B Purchase CARROLL J MARTIN
5,000 +27.1%
20.42
US$102,094 		5,000 +27.1% 20.42 US$102,094
2017-11-13 2017-11-09 B Purchase CARLUCCI DAVID R
10,000 +62.4%
21.83
US$218,349 		10,000 +62.4% 21.83 US$218,349
2017-09-01 2017-08-30 PP Planned purchase Fischer Meredith B

Chief Public Affairs Officer
1,280 +4.7%
39.63
US$50,725 		1,280 +4.7% 39.63 US$50,725
2017-06-12 2017-06-09 PP Planned purchase Romano Steven J.

Exec. VP & Chief Sci. Ofcr
1,000 +4.7%
39.88
US$39,881 		1,000 +4.7% 39.88 US$39,881
2017-06-12 2017-06-09 B Purchase Lannum Coleman N III

Sr. VP Investor Strategy & IRO
1,400 +87.5%
39.77
US$55,678 		1,400 +87.5% 39.77 US$55,678
2017-06-12 2017-06-09 B Purchase Lannum Coleman N III

Sr. VP Investor Strategy & IRO
1,550 +4.9%
39.89
US$61,825 		1,550 +4.9% 39.89 US$61,825
2017-06-12 2017-06-09 PP Planned purchase LLOYD RONALD K.

Exec. VP & Pres, Hospital
5,000 +38.6%
41.26
US$206,320 		5,000 +38.6% 41.26 US$206,320
2017-06-12 2017-06-09 PP Planned purchase Trudeau Mark

President and CEO

Executive Director
1,000 +0.4%
40.17
US$40,174 		1,000 +0.4% 40.17 US$40,174
2017-06-12 2017-06-08 PP Planned purchase O'Neill Hugh M.

Exec. VP & Pres, ARD
1,000 +3.3%
40.24
US$40,237 		1,000 +3.3% 40.24 US$40,237
2017-06-07 2017-06-05 B Purchase Lannum Coleman N III

Sr. VP Investor Strategy & IRO
500 +1.6%
39.33
US$19,665 		500 +1.6% 39.33 US$19,665
Explore more

More insider trading research around Keenova Therapeutics PLC

More insider trades in IE
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity